Uterine rupture during therapeutic abortion in the second trimester using mifepristone and prostaglandin. 1995

K J Thong, and P Lynch, and D T Baird

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011262 Pregnancy Trimester, Second The middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation. Midtrimester,Pregnancy, Second Trimester,Trimester, Second,Midtrimesters,Pregnancies, Second Trimester,Pregnancy Trimesters, Second,Second Pregnancy Trimester,Second Pregnancy Trimesters,Second Trimester,Second Trimester Pregnancies,Second Trimester Pregnancy,Second Trimesters,Trimesters, Second
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000020 Abortifacient Agents, Nonsteroidal Non-steroidal chemical compounds with abortifacient activity. Abortifacient Agents, Non-Steroidal,Abortifacient Agents, Non Steroidal,Agents, Non-Steroidal Abortifacient,Agents, Nonsteroidal Abortifacient,Non-Steroidal Abortifacient Agents,Nonsteroidal Abortifacient Agents
D000021 Abortifacient Agents, Steroidal Steroidal compounds with abortifacient activity. Steroid Abortifacients,Abortifacients, Steroid,Agents, Steroidal Abortifacient,Steroidal Abortifacient Agents
D000032 Abortion, Therapeutic Abortion induced to save the life or health of a pregnant woman. (From Dorland, 28th ed) Therapeutic Abortion,Abortions, Therapeutic,Therapeutic Abortions
D000527 Alprostadil A potent vasodilator agent that increases peripheral blood flow. PGE1,Prostaglandin E1,Caverject,Edex,Lipo-PGE1,Minprog,Muse,PGE1alpha,Prostaglandin E1alpha,Prostavasin,Prostin VR,Prostine VR,Sugiran,Vasaprostan,Viridal,Lipo PGE1
D014597 Uterine Rupture A complete separation or tear in the wall of the UTERUS with or without expulsion of the FETUS. It may be due to injuries, multiple pregnancies, large fetus, previous scarring, or obstruction. Rupture, Uterine,Ruptures, Uterine,Uterine Ruptures
D015735 Mifepristone A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING SYNDROME. Mifegyne,Mifeprex,Mifégyne,R-38486,R38486,RU-38486,RU-486,ZK-98296,ZK98296,R 38486,RU 38486,RU 486,RU38486,RU486,ZK 98296

Related Publications

K J Thong, and P Lynch, and D T Baird
April 1995, British journal of obstetrics and gynaecology,
K J Thong, and P Lynch, and D T Baird
April 1996, European journal of obstetrics, gynecology, and reproductive biology,
K J Thong, and P Lynch, and D T Baird
January 2005, Fetal diagnosis and therapy,
K J Thong, and P Lynch, and D T Baird
July 2003, Ugeskrift for laeger,
K J Thong, and P Lynch, and D T Baird
November 2001, Obstetrics and gynecology,
K J Thong, and P Lynch, and D T Baird
September 2020, Journal of Nepal Health Research Council,
K J Thong, and P Lynch, and D T Baird
October 1995, Geburtshilfe und Frauenheilkunde,
K J Thong, and P Lynch, and D T Baird
March 1985, European journal of obstetrics, gynecology, and reproductive biology,
Copied contents to your clipboard!